featured
Trimethoprim–Sulfamethoxazole With Spironolactone Increases Risk for Sudden Death
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
CMAJ : Canadian Medical Association Journal
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Trimethoprim-Sulfamethoxazole and Risk of Sudden Death Among Patients Taking Spironolactone
CMAJ 2015 Feb 02;[EPub Ahead of Print], T Antoniou, S Hollands, EM Macdonald, T Gomes, MM Mamdani, DN JuurlinkFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.